Winsrow 50 Mg 50 Tablets Crowx Labs USA

Product Overview

Winsrow 50 mg 50 Tablets Crowx Labs USA presents stanozolol, a synthetic dihydrotestosterone derivative classified as an anabolic steroid, in the standard 50 mg oral tablet strength. Each retail unit contains 50 tablets with embedded hologram and 12-digit verification coding, providing experienced buyers pharmaceutical-grade presentation with authenticity controls matching GMP standards.​

The product belongs to Crowx Labs USA’s domestic anabolic range, manufactured across U.S./EU/Asia facilities with high-purity raw materials and security features distinguishing originals from counterfeits. This configuration supports U.S.-based eCommerce platforms emphasizing verified sourcing, domestic warehousing, and CIII-compliant distribution channels.​

Winsrow targets knowledgeable adult consumers (21+) familiar with Schedule III anabolic steroids rather than general supplement categories, focusing exclusively on commercial specifications, verification protocols, and controlled availability.​

Brand & Manufacturer Information

Crowx Labs USA operates multi-continental production (USA/EU/Asia) specializing in GMP-standard anabolic steroids, HGH, SARMs, and PCT products with U.S. domestic warehousing. Winsrow features proprietary hologram stickers and scratch-off verification codes queryable via crowxlabs.net, enabling instant authenticity confirmation.​

Domestic focus eliminates customs exposure while lab test results validate purity/potency claims across the catalog. Consistent 50 mg tablet morphology, security packaging, and brand holograms support professional resellers maintaining DEA-compliant inventory tracking and customer verification workflows.​

Active Compound Information

Winsrow contains stanozolol (17α-methyl-2’H-5α-androst-2-enopyrazol-17β-ol), a heterocyclic 17α-alkylated DHT derivative with pyrazole ring at C2-C3 and no aromatization capability. Schedule III controlled substance (CIII) exhibiting high anabolic:androgenic ratio; 8-hour half-life supports frequent research applications.​

Stanozolol appears on WADA S1 Prohibited List; non-medical possession regulated under 21 CFR 1308.13, EU Directive 2004/24/EC equivalents. This listing identifies chemical classification without describing mechanisms, indications, or protocols.​

Product Specifications

• Product name: Winsrow 50 mg 50 Tablets Crowx Labs USA

• Brand/manufacturer: Crowx Labs USA​

• Active compound: Stanozolol​

• Strength: 50 mg per tablet​

• Quantity per pack: 50 tablets​

• Dosage form: Oral tablets

• Category: Anabolic steroid, DEA Schedule III​

• Security features: Hologram + 12-digit verification code​

• Primary packaging: Sealed bottle with tamper-evident seal​

• Label elements: 50 mg declaration, batch code, hologram, verification field​

Quality Control & Testing Standards

Crowx Labs manufactures to GMP standards with published lab test results verifying stanozolol identity, 50 mg potency (±5% assay), and absence of contaminants. Hologram/verification system prevents counterfeiting; multi-facility production maintains batch consistency across U.S. domestic supply.​

Third-party analytics confirm pharmaceutical-grade purity distinguishing Crowx products from underground conversions prone to under-dosing or adulteration prevalent in non-verified markets.​

Intended Use & Market Positioning

Winsrow 50 mg 50 Tablets serves CIII-authorized researchers, advanced competitors (21+), and institutional buyers managing Schedule III anabolic inventories. 50 mg strength with verification coding positions within premium domestic catalogs excluding recreational segments. No protocols or outcomes represented.​

Packaging, Storage & Handling

Tamper-evident bottles with hologram seals protect from light/moisture; verification code activates via crowxlabs.net post-receipt. Store 20-25°C locked environment per DEA protocols; inventory logged with lot numbers supporting audit trails.​

Purchasing & Availability Information

Domestic U.S. platforms offer encrypted CIII-compliant checkout, age verification, and unmarked USPS Priority shipping from verified warehouses. Hologram/scannable coding enables pre-purchase authenticity preview; consistent SKU supports institutional repeat procurement without customs delays.​

Legal & Regulatory Disclaimer

Stanozolol constitutes DEA Schedule III controlled substance; non-medical manufacture, distribution, possession violates 21 USC §812. Buyer assumes complete Form 222/DEA compliance responsibility across jurisdictions; zero medical claims, dosing guidance, or protocols provided.​